← Back to headlines
Goldman Sachs Predicts Significant Upside for Dell and New Medtech Stock
Goldman Sachs analysts are bullish on the stock performance of Dell, suggesting its recent surge is not over, and also predict a potential doubling for a medtech stock that began trading less than a month ago. The firm sees significant growth potential in both companies.
2 Jun, 11:46 — 2 Jun, 13:29
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left2
Left (2)
Yahoocnbc
Center
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual70d ago
This medtech stock began trading less than a month ago. Goldman Sachs thinks it could double
The investment bank initiated coverage of the neurostimulation therapy developer with a buy rating.
Read full article →YahooMostly Factual69d ago
Why the epic Dell stock price surge isn't over, Goldman Sachs says
Read full article →Coverage Timeline
First report: cnbc · 2 Jun, 11:46|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
